[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  RedboxGlobal India [@REDBOXINDIA](/creator/twitter/REDBOXINDIA) on x 367.9K followers Created: 2025-06-05 04:06:43 UTC POSITIVE FOR LUPIN BIG RELIEF IN MIRABEGRON CASE – VERY LARGE DRUG FOR LUPIN *BLOOMBERG LAW REPORTS* Two generic-drug makers can raise a new invalidity defense at a 2026 jury trial against one patents Astellas Pharma Inc. alleges their Myrbetriq ER copies infringe JUDGE NOTED Astellas would face little harm, noting the parties had already developed an obviousness record XXXXXX engagements  **Related Topics** [harm](/topic/harm) [astellas pharma](/topic/astellas-pharma) [$4503t](/topic/$4503t) [stocks defense](/topic/stocks-defense) [bloomberg](/topic/bloomberg) [india](/topic/india) [Post Link](https://x.com/REDBOXINDIA/status/1930476350306955518)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RedboxGlobal India @REDBOXINDIA on x 367.9K followers
Created: 2025-06-05 04:06:43 UTC
POSITIVE FOR LUPIN
BIG RELIEF IN MIRABEGRON CASE – VERY LARGE DRUG FOR LUPIN
BLOOMBERG LAW REPORTS Two generic-drug makers can raise a new invalidity defense at a 2026 jury trial against one patents Astellas Pharma Inc. alleges their Myrbetriq ER copies infringe JUDGE NOTED Astellas would face little harm, noting the parties had already developed an obviousness record
XXXXXX engagements
Related Topics harm astellas pharma $4503t stocks defense bloomberg india
/post/tweet::1930476350306955518